Variable manifestation in natural killer cell leukaemia

Clinical and Laboratory Haematology

Volumn 25, Issue 4, 2003, Pages 239-245

  Kuroda, J ^a,b   Kimura, S ^a   Kobayashi, Y ^b   Jyoko, N ^b   Kamitsuji, Y ^b   Murotani, Y ^b,c   Fukuda, W ^c   Akaogi, T ^c   Hayashi, H ^c   Yoshikawa, T ^b   Maekawa, T ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KYOTO SECOND RED CROSS HOSPITAL   (Japan)

Author keywords

Bone marrow transplantation; CD4; Hypogranular variant; Natural killer cell leukaemia; Spectral karyotyping

Indexed keywords

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER INVASION; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; CYTOLOGY; GENETIC ANALYSIS; HEMATOLOGIC DISEASE; HUMAN; LEUKEMIA; LONG TERM CARE; LYMPHOMA; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, NEOPLASM; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; KILLER CELLS, NATURAL; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; PEROXIDASE; PHENOTYPE; PROGNOSIS; TUMOR STEM CELLS;

EID: 12444332627     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.2003.00528.x     Document Type: Article

References (25)

1. Akashi K. & Mizuno S. (2000) Epstein-Barr virus-infected natural killer cell leukemia. Leukemia and Lymphoma 40, 57-66.
2. Akashi K., Shibuya T., Harada M., Takamatsu Y., Uike N., Eto T. & Niho Y. (1991) Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells. Journal of Clinical Investigation 88, 223-230.
3. Chan J.K. (1998) Natural killer cell neoplasms. Anatomic Pathology 3, 77-145.
4. Chaperot L., Bendriss N., Manches O., Gressin R., Maynadie M., Trimoreau F., Orfeuvre H., Corront B., Feuillard J., Sotto J.J., Bensa J.C., Briere F., Plumas J. & Jacob M.C. (2001) Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 97, 3210-3217.
5. Charamella L.J., Meyer C., Thompson G.E. & Dimitrov N.V. (1985) Chemotherapeutic agents and modulation of natural killer cell activity in vitro. Journal of Immunopharmacology 7, 53-65.
6. Egashira S., Kawamata N., Sugimoto K., Kaneko T. & Oshimi, K. (1999) P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833. Blood 93, 599-606.
7. Jaffe E.S., Chan J.K.C., Su I-J., Frizzera G., Mori S., Feller A.C. & Ho F.C.S. (1996) Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. The American Journal of Surgical Pathology 20, 103-111.
8. Jyoko N., Kuroda J., Kimura S., Kobayashi Y. & Yoshikawa T. (2002) Comprehensive cytogenetic study by spectral karyotyping on blastic natural killer cell leukemia/lymphoma. The American Journal of Hematology 69, 234-235.
9. Kakazu N., Taniwaki M., Horiike S., Nishida K., Tatekawa T., Nagai M., Takahashi T., Akaogi T., Inazawa J., Ohki M. & Abe T. (1999) Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome. Genes Chromosomes and Cancer 26, 336-345.
10. Kaneko T., Fukuda J., Yoshihara T., Zheng H., Mori S., Mizoguchi H. & Oshimi K. (1995) Nasal natural killer (NK) cell lymphoma: report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen, and comprehensive studies of their phenotype and cytotoxity with normal NK cells. British Journal of Haematology 91, 355-361.
11. Kimura S., Kakazu N., Kuroda J., Akaogi T., Hayashi H., Nishida K. & Abe T. (2001) Agranular CD4+CD56+ blastic natural killer leukemta/lymphoma. Annals of Hematology 80, 228-231.
12. Kuroda J., Kimura S., Akaogi T., Hayashi H., Nishida K., Kakazu N. & Abe T. (2000) Aggressive natural killer cell leukemia/lymphoma: a comprehensive cytogenetic study by spectral karyotyping. Annals of Hematology 79, 519-522.
13. Manabe A., Takahashi K., Shibata R., Takeuchi M., Morita M. & Hosoya R. (2000) Long-term remission induced by corticosteroids, cyclophosphamide, and methotrexate in a patient with natural killer cell leukemia. Medical and Pediatric Oncology 34, 224-225.
14. Mitelman F. (1995) International System for Human Cytogenetic Nomenclature, S Karger, Basel.
15. Mori N., Yatabe Y., Oka K., Kinoshita T., Kobayashi T., Ono T. & Asai J. (1996) Expression of perforin in nasal lymphoma additional evidence of its natural killer cell derivation. The American Journal of Pathology 149, 699-705.
16. Nakamura S., Suchi T., Koishikawa T., Kitoh K., Koike K., Komatsu H., Iida S., Kagami Y., Ogura M. & Katoh E. (1995) Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. The American Journal of Surgical Pathology 19, 284-296.
17. Obama K., Tara M. & Niina K. (1999) L-asparaginase induced complete remission in Epstein-Barr virus positive, multidrug resistant, cutaneous T-cell lymphoma. International Journal of Hematology 69, 260-262.
18. Ohshima K., Suzumiya J., Shimazaki K., Kato A., Kanda M. & Kikuchi M. (1997) Nasal T/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage. Histopathology 31, 444-450.
19. Raab-Traub N. & Flynn K. (1986) The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47, 883-889.
20. Rakozy C.K., Mohamed A.N., Vo T.D., Khatib G.K., Long P.M., Eilender D. & Palutke M. (2001) CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse. The American Journal of Clinical Pathology 116, 168-176.
21. Siu L.L., Wong K.F., Chan J.K. & Kwong Y.L. (1999) Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations. The American Journal of Pathology 155, 1419-1425.
22. Siu L.L., Chan V., Chan J.K., Wong K.F., Llang R. & Kwong Y.L. (2000) Consistent patterns of allelic loss in natural killer cell lymphoma. The American Journal of Pathology 157, 1803-1809.
23. Suda T., Hashimoto H., Tanaka M., Ochi T. & Nagata S. (1997) Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks killing. The Journal of Experimental Medicine 186, 2045-2050.
24. Suminoe A., Matsuzaki A., Takada H., Hattori H., Furuno K., Takemoto M., Maki H., Kanaya N., Ohnuma K., Nishihira H. & Hara T. (2000) An infant with precursor natural killer (NK) cell leukemia successfully treated with an unrelated cord blood transplantation. Leukemia and Lymphoma 39, 641-646.
25. Tanimoto M., Miyawaki S., Ino T., Kyo T., Sakamaki H., Naoe T., Hiraoka A., Asou N., Ohshima T., Tsubaki K., Kuriyama K., Ueda T., Minami S., Okabe K., Saito H., Murakami H., Hirano M., Dohi H., Onozawa Y., Suzuki H. & Ohno R. (1998) Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia. The ALL-87 study of the Japan Adult Leukemia Study Group. International Journal of Hematology 68, 421-429.